This application requests Cancer Center Support Grant funding for The University of Iowa Cancer Center (UICC). The UICC is based in the University of Iowa College of Medicine and the University of Iowa Hospitals and Clinics which is the designated tertiary care medical center for the state of Iowa. The University of Iowa Cancer Center was established in 1980 to coordinate the cancer-related research, clinical and educational activities of the University of Iowa. Recent additional institutional support to the UICC has strengthened the role of the Center in directing and coordinating all cancer research activities within the University. Among these commitments are the current UICC clinical facilities that house the inpatient, outpatient, clinical research and administrative activities of the UICC, and a new cancer research building that will supply over 30,000 square feet of laboratory space for UICC investigators. The UICC functions administratively as a matrix center with 123 members from six colleges and 27 departments across the University. The members of the UICC have $26,184,734 of cancer- related external research support annually. The UICC is organized into six research programs including 1) Cancer Epidemiology, 2) Cellular Activation in Cancer, 3) Experimental Therapeutics, 4) Free Radicals and Membranes, 5) Molecular and Tumor Virology, and 6) Molecular Mechanisms of Metastasis. In addition, the UICC supports four shared resources including 1) Flow Cytometry, 2) Tissue Culture/Hybridoma, 3) Biostatistics and 4) Clinical Trials Support. Through these programs and cores, the UICC enhances interactions, supports collaborations, and 4) Clinical Trials Support. Through these programs and cores, the UICC enhances interactions, support collaborations, and sets the direction of future cancer research activities. Additional UICC activities include a rigorous planning and evaluation process and a variety of pilot grant programs for UICC members designed to support new investigators and encourage development of new collaborations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-04
Application #
6657995
Study Section
Subcommittee G - Education (NCI)
Program Officer
Silkensen, Shannon M
Project Start
2000-07-14
Project End
2005-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
4
Fiscal Year
2003
Total Cost
$1,558,668
Indirect Cost
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Kim, Yusung; Cabel, Katherine; Sun, Wenqing (2018) Does the apex optimization line matter for single-channel vaginal cylinder brachytherapy planning? J Appl Clin Med Phys 19:307-312
Hagan, Teresa L; Gilbertson-White, Stephanie; Cohen, Susan M et al. (2018) Symptom Burden and Self-Advocacy: Exploring the Relationship Among Female Cancer Survivors?. Clin J Oncol Nurs 22:E23-E30
Chesney, Jason; Puzanov, Igor; Collichio, Frances et al. (2018) Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma. J Clin Oncol 36:1658-1667
Brooks, Jennifer D; Comen, Elizabeth A; Reiner, Anne S et al. (2018) CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study. Breast Cancer Res 20:149
Chioreso, Catherine; Del Vecchio, Natalie; Schweizer, Marin L et al. (2018) Association Between Hospital and Surgeon Volume and Rectal Cancer Surgery Outcomes in Patients With Rectal Cancer Treated Since 2000: Systematic Literature Review and Meta-analysis. Dis Colon Rectum 61:1320-1332
Musselman, Catherine A; Kutateladze, Tatiana G (2018) A histone reader becomes the readout. J Biol Chem 293:7486-7487
Merritt, Nicole M; Fullenkamp, Colleen A; Hall, Sarah L et al. (2018) A comprehensive evaluation of Hippo pathway silencing in sarcomas. Oncotarget 9:31620-31636
Haskins, Cole B; McDowell, Bradley D; Carnahan, Ryan M et al. (2018) Impact of preexisting mental illness on breast cancer endocrine therapy adherence. Breast Cancer Res Treat :
Daneshmand, Siamak; Patel, Sanjay; Lotan, Yair et al. (2018) Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study. J Urol 199:1158-1165
Borcherding, Nicholas; Kolb, Ryan; Gullicksrud, Jodi et al. (2018) Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer. J Mol Biol 430:2014-2029

Showing the most recent 10 out of 1080 publications